Amarin Corp Plc (AMRN)

[everyonesguess]

Be patient.

The situation was ordinary holders anxiously looking for an early stop at 80% IA, though V needs as many events as possible from RI -- the completion is fitting the max interest. The options ($6 - $8 Calls of Aug and Sep) also reflect the anxieties, and they will expire worthlessly.

The dark force always keeps a pressure on AMRN's PPS. In fact, with current $170M annual revenue, the fair market value for a growing Bio would be 7 x revenue = 1.19B. But it is less than $0.9B now for AMRN.

AMRN will be trading low before the RI completion. Fortunately, RI only needs a label extension. So, when RI completes, 3-4 months may be enough for FDA review and approve the new RI label.